Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000171731 | SCV000055246 | likely benign | not provided | 2013-06-24 | criteria provided, single submitter | research | |
Labcorp Genetics |
RCV001087509 | SCV000563346 | benign | Long QT syndrome | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000619885 | SCV000737814 | likely benign | Cardiovascular phenotype | 2019-01-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV002253262 | SCV002524889 | benign | Long QT syndrome 11 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000171731 | SCV005221019 | likely benign | not provided | criteria provided, single submitter | not provided |